Approval · Notice of Compliance 13613 · 2012
ACCEL-CLARITHROMYCIN: Notice of Compliance 13613
Issued August 31, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13613
- Date
- August 31, 2012
- Company
- Accel Pharma IncPointe Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antibiotic
- Canadian reference product
- BIAXIN (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACCEL-CLARITHROMYCIN | 02390442 | Marketed |
| ACCEL-CLARITHROMYCIN | 02390450 | Marketed |
Medicinal ingredients
- CLARITHROMYCIN 125 MG per 5ML
- CLARITHROMYCIN 250 MG per 5ML